Strategies to Suspension Serum-Free Adaptation of Mammalian Cell Lines for Recombinant Glycoprotein Production

Part of the Methods in Molecular Biology book series (MIMB, volume 1674)


Serum-free suspension cultures are preferably required for recombinant protein production due to its readiness in upstream/downstream processing and scale-up, therefore increasing process productivity and competitiveness. This type of culture replaces traditional cell culturing as the presence of animal-derived components may introduce lot-a-lot variability and adventitious pathogens to the process. However, adapting cells to serum-free conditions is challenging, time-consuming, and cell line and medium dependent. In this chapter, we present different approaches that can be used to adapt mammalian cell lines from an anchorage-dependent serum supplemented culture to a suspension serum-free culture.

Key words

Adaptation Cell culture Human cell lines Mammalian cell lines Serum-free medium Suspension culture 



This work was supported by FAPESP grants 2012/04629-8 and 2012/02109-7 and CAPES scholarship.


  1. 1.
    Rodrigues ME, Costa AR, Henriques M et al (2013) Advances and drawbacks of the adaptation to serum-free culture of CHO-K1 cells for monoclonal antibody production. Appl Biochem Biotechnol 169:1279–1291CrossRefPubMedGoogle Scholar
  2. 2.
    Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393–1398CrossRefPubMedGoogle Scholar
  3. 3.
    Grillberger L, Kreil TR, Nasr S, Reiter M (2009) Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells. Biotechnol J 4:186–201CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Johnson T (2006) Promises and pitfalls of cell line adaptation. BioProcess Int 3:S52–S56Google Scholar
  5. 5.
    Costa AR, Withers J, Rodrigues ME et al (2013) The impact of cell adaptation to serum-free conditions on the glycosylation profile of a monoclonal antibody produced by Chinese hamster ovary cells. New Biotechnol 30:563–572CrossRefGoogle Scholar
  6. 6.
    Gstraunthaler G (2003) Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX 20:275–281PubMedGoogle Scholar
  7. 7.
    van der Valk J, Brunner D, De Smet K et al (2010) Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24:1053–1063CrossRefPubMedGoogle Scholar
  8. 8.
    van der Valk J, Mellor D, Brands R et al (2004) The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro 18:1–12CrossRefPubMedGoogle Scholar
  9. 9.
    Chico E, Rodríguez G, Figueredo A (2008) Biorreatores para Células Animais. In: Moraes Â, Augusto E, Castilho L (eds) Tecnol. Cultiv. Células Animais Biofármacos a Ter. Gênica, 1st edn. Roca, Barcelona, Spain, p 528Google Scholar
  10. 10.
    Freshney IR (2015) Culture of animal cells: a manual of basic technique and specialized applications. In: Culture of animal cells, 6th edn. John Wiley & Sons, Inc., Hoboken, NJ, USA, pp i–xxxiGoogle Scholar
  11. 11.
    Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30:1158–1170CrossRefPubMedGoogle Scholar
  12. 12.
    Costa A, Rodrigues M, Henriques M et al (2011) Strategies for adaptation of mAb-producing CHO cells to serum-free medium. BMC Proc 5:P112CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    do Amaral RL, de Sousa Bomfim A, de Abreu-Neto MS et al (2016) Approaches for recombinant human factor IX production in serum-free suspension cultures. Biotechnol Lett 38:385–394CrossRefPubMedGoogle Scholar
  14. 14.
    Biaggio RT, Abreu-Neto MS, Covas DT, Swiech K (2015) Serum-free suspension culturing of human cells: adaptation, growth, and cryopreservation. Bioprocess Biosyst Eng 38(8):1495–1507CrossRefPubMedGoogle Scholar
  15. 15.
    González Hernández Y, Fischer RW (2007) Serum-free culturing of mammalian cells--adaptation to and cryopreservation in fully defined media. ALTEX 24:110–116CrossRefPubMedGoogle Scholar
  16. 16.
    Jaluria P, Konstantopoulos K, Betenbaugh M, Shiloach J (2008) Egr1 and Gas6 facilitate the adaptation of HEK-293 cells to serum-free media by conferring enhanced viability and higher growth rates. Biotechnol Bioeng 99:1443–1452CrossRefPubMedGoogle Scholar
  17. 17.
    Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A (2012) Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev 28:147–175CrossRefPubMedGoogle Scholar
  18. 18.
    Côté J, Garnier A, Massie B, Kamen A (1998) Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Biotechnol Bioeng 59:567–575CrossRefPubMedGoogle Scholar
  19. 19.
    Cho MS, Yee H, Chan S (2002) Establishment of a human somatic hybrid cell line for recombinant protein production. J Biomed Sci 9:631–638CrossRefPubMedGoogle Scholar
  20. 20.
    Schiedner G, Hertel S, Bialek C et al (2008) Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection. BMC Biotechnol 8:13CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Perrin P, Madhusudana S, Gontier-Jallet C et al (1995) An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Vaccine 13:1244–1250CrossRefPubMedGoogle Scholar
  22. 22.
    Haldankar R, Kopchick JJ, Ridgway D (1999) Stable production of a human growth hormone antagonist from CHO cells adapted to serum-free suspension culture. Biotechnol Prog 15:336–346CrossRefPubMedGoogle Scholar
  23. 23.
    Pau MG, Ophorst C, Koldijk MH et al (2001) The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 19:2716–2721CrossRefPubMedGoogle Scholar
  24. 24.
    Corning (2012) Adaptation of cell cultures to a serum-free medium - SFM adaptation protocol. In: Invitrogen. of Cell Cultures to a Serum-free Medium.pdf. Accessed 9 Jan 2017

Copyright information

© Springer Science+Business Media LLC 2018

Authors and Affiliations

  1. 1.Center for Cell-based Therapy CTC, Ribeirão Preto Medical SchoolUniversity of São PauloRibeirão Preto-SPBrazil
  2. 2.School of Pharmaceutical Sciences of Ribeirão PretoUniversity of São PauloRibeirão PretoBrazil

Personalised recommendations